tumCV Cancer Research Results

tumCV, Cell Viability: Click to Expand ⟱

Source:

Type:

Cell Viability

Scientific Papers found: Click to Expand⟱

8330-

,

SIRT3-SOD2-ROS pathway is involved in linalool-induced glioma cell apoptotic death

-

in-vitro,

GBM,

U87MG

tumCV↓, OCR↓, BAX↑, Bak↑, Bcl-2↓, Bcl-xL↓, Casp3↑, Casp9↑, Apoptosis↑, SOD↓, SIRT3↓, mt-ROS↑,

7857-

3BP,

A Mechanism of Isoorientin-Induced Apoptosis and Migration Inhibition in Gastric Cancer AGS Cells

-

in-vitro,

NA,

AGS

tumCV↓, selectivity↑, *toxicity↓, Apoptosis↑, ROS↑, eff↓, TumCCA↑, p‑Akt↓, p‑GSK‐3β↓, β-catenin/ZEB1↓, TumCMig↓, Twist↓, N-cadherin↑, β-catenin/ZEB1↓, E-cadherin↑,

5259-

3BP,

Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP

-

in-vivo,

HCC,

NA

highly glycolytic cancers.  young rats. Advanced cancers (2-3cm) developed

ATP↓, TumCD↑, toxicity↓, eff↑, tumCV↓, Dose↝,

5236-

AgNPs,

Adaptive regulations of Nrf2 alleviates silver nanoparticles-induced oxidative stress-related liver cells injury

-

in-vitro,

Liver,

HepG2

-

in-vitro,

Nor,

L02

tumCV↓, ROS↑, *ROS↑, DNAdam↑, *DNAdam↑, eff↓, selectivity↑,

4403-

AgNPs,

Silver Nanoparticles Decorated UiO-66-NH2 Metal-Organic Framework for Combination Therapy in Cancer Treatment

-

in-vitro,

GBM,

U251

-

in-vitro,

GBM,

U87MG

-

in-vitro,

GBM,

GL26

-

in-vitro,

Cerv,

HeLa

-

in-vitro,

CRC,

RKO

AntiCan↑, eff↑, EPR↑, selectivity↑, ROS↑, Casp↑, Apoptosis↑, DNAdam↑, tumCV↓, eff↑,

4397-

AgNPs,

Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity

-

NA,

Wounds,

NA

 99 nm, with a zeta potential of −6 mV

selectivity↑, tumCV↓, antiOx↑, Inflam↓,

4396-

AgNPs,

Identification of possible reductants in the aqueous leaf extract of mangrove plant Rhizophora apiculata for the fabrication and cytotoxicity of silver nanoparticles against human osteosarcoma MG-63 cells

-

in-vitro,

OS,

MG63

AntiCan↑, tumCV↓,

4389-

AgNPs,

Graphene Oxide-Silver Nanocomposite Enhances Cytotoxic and Apoptotic Potential of Salinomycin in Human Ovarian Cancer Stem Cells (OvCSCs): A Novel Approach for Cancer Therapy

-

in-vitro,

Ovarian,

NA

tumCV↓, ROS↑, LDH↓, MMP↑, CSCs↓, AntiCan↑,

4388-

AgNPs,

Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells

-

in-vitro,

Cerv,

NA

47.5 nm

tumCV↓, CSCs↓, selectivity↑, Apoptosis↑, ROS↑, LDH↓, Casp3↑, BAX↑, Bak↑, cMyc↑, MMP↓,

4415-

AgNPs,

SDT,

CUR,

Examining the Impact of Sonodynamic Therapy With Ultrasound Wave in the Presence of Curcumin-Coated Silver Nanoparticles on the Apoptosis of MCF7 Breast Cancer Cells

-

in-vitro,

BC,

MCF7

29.3 ± 5.6 nm

 48.23 µg/ml

SDT was performed using an US frequency of 1 MHz, intensity of 2 W/cm2, and a distance of 2 cm.

tumCV↓, BAX↑, Casp3↑, Bcl-2↓, eff↑, ROS↑, sonoS↑, eff↑, MMP↓, Cyt‑c↑,

4411-

AgNPs,

Eco-friendly synthesis of silver nanoparticles using Anemone coronaria bulb extract and their potent anticancer and antibacterial activities

-

in-vitro,

Lung,

A549

-

in-vitro,

PC,

MIA PaCa-2

-

in-vitro,

Pca,

PC3

-

in-vitro,

Nor,

HEK293

AntiCan↑, selectivity↑, Apoptosis↑, TumCCA↑, Bacteria↓, tumCV↓, selectivity↑, Apoptosis↑, TumCCA↑,

4410-

AgNPs,

Green-synthesized silver nanoparticles: a sustainable nanoplatform for targeted colon cancer therapy

-

Review,

Colon,

NA

AntiCan↑, ROS↑, mtDam↑, tumCV↓, selectivity↑,

4409-

AgNPs,

Plant-based synthesis of gold and silver nanoparticles using Artocarpus heterophyllus aqueous leaf extract and its anticancer activities

-

in-vitro,

BC,

MCF7

12.75 nm

54.981 µg/mL

tumCV↓, TumCCA↑, cycD1/CCND1↓, COX2/PTGS2↓, HER2/EBBR2↓,

4408-

AgNPs,

Chitosan-coated silver nanoparticles synthesized using Moringa oleifera flower extract: A potential therapeutic approach against triple-negative breast cancer

-

in-vitro,

BC,

MDA-MB-231

 27 ± 0.5 μg/mL

tumCV↓,

4406-

AgNPs,

Silver nanoparticles achieve cytotoxicity against breast cancer by regulating long-chain noncoding RNA XLOC_006390-mediated pathway

-

in-vitro,

BC,

MCF7

63.1 ± 8.3 nm

tissues from 64 patients

-

in-vitro,

BC,

T47D

-

in-vitro,

BC,

MDA-MB-231

TumCD↑, other↓, P53↑, TumCCA↑, Apoptosis↑, ChemoSen↑, tumCV↓, γH2AX↑, SOX4↓,

4427-

AgNPs,

Silver nanoparticles induce apoptosis and G2/M arrest via PKCζ-dependent signaling in A549 lung cells

-

in-vitro,

Lung,

A549

tumCV↓, LDH↑, TumCCA↑, BAX↑, BID↑, Bcl-2↓, PKCδ↓,

4428-

AgNPs,

p38 MAPK Activation, DNA Damage, Cell Cycle Arrest and Apoptosis As Mechanisms of Toxicity of Silver Nanoparticles in Jurkat T Cells

-

in-vitro,

AML,

Jurkat

toxicity↝, tumCV↓, ROS↑, p38↑, NRF2↓, NF-kB↝, DNAdam↑, Apoptosis↑,

4380-

AgNPs,

Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways

-

in-vitro,

Lung,

A549

ROS↑, tumCV↓, MMP↓, TumCCA↑, PCNA↓, eff↓,

4370-

AgNPs,

Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line

-

in-vitro,

Liver,

HepG2

 30.71 nm

75 μg/mL

tumCV↓, ROS↑, Apoptosis↑,

4555-

AgNPs,

Silver nanoparticles from Dendropanax morbifera Léveille inhibit cell migration, induce apoptosis, and increase generation of reactive oxygen species in A549 lung cancer cells

-

in-vitro,

Lung,

A549

-

in-vitro,

Liver,

HepG2

*Bacteria↓, tumCV↓, selectivity↑, ROS↑, Apoptosis↑, TumCMig↓, AntiCan↑,

4549-

AgNPs,

Silver nanoparticles: Synthesis, medical applications and biosafety

-

Review,

Var,

NA

-

Review,

Diabetic,

NA

ROS↑, eff↑, other↝, DNAdam↑, EPR↑, eff↑, eff↑, TumMeta↓, angioG↓, *Bacteria↓, *eff↑, *AntiViral↑, *AntiFungal↑, eff↑, eff↑, TumCP↓, tumCV↓, P53↝, HIF-1↓, TumCCA↑, lipid-P↑, ATP↓, Cyt‑c↑, MMPs↓, PI3K↓, Akt↓, *Wound Healing↑, *Inflam↓, *Bone Healing↑, *glucose↓, *AntiDiabetic↑, *BBB↑,

346-

AgNPs,

RSQ,

Investigating Silver Nanoparticles and Resiquimod as a Local Melanoma Treatment

-

in-vivo,

Melanoma,

SK-MEL-28

 AgNP (2 mg/kg) and RSQ (25 mg/kg) administration routes used were peri- and intratumora

 mice

-

in-vivo,

Melanoma,

WM35

ROS↑, Ca+2↝, Casp3↑, Casp8↑, Casp9↑, CD4+↑, CD8+↑, tumCV↓, eff↓, *toxicity↓,

2539-

AgNPs,

SDT,

Combined effect of silver nanoparticles and therapeutical ultrasound on ovarian carcinoma cells A2780

-

in-vitro,

Melanoma,

A2780S

tumCV↓, sonoP↑, BioEnh↑,

7426-

AgNPs,

CS,

Silver Nanoparticles Formulation of Flower Head's Polyphenols of Cynara scolymus L.: A Promising Candidate against Prostate (PC-3) Cancer Cell Line through Apoptosis Activation

-

in-vitro,

Pca,

PC3

0.85 μg/mL

-

in-vitro,

Lung,

A549

 0.94 μg/mL

*antiOx↑, tumCV↓, eff↑, Dose↝, P53↑, BAX↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓,

246-

AL,

Allicin induces apoptosis of the MGC-803 human gastric carcinoma cell line through the p38 mitogen-activated protein kinase/caspase-3 signaling pathway

-

in-vitro,

GC,

MGC803

 0-10ug/ml

Apoptosis↑, cl‑Casp3↑, p38↑, tumCV↓, BAX↑, Bcl-2↑,

250-

AL,

Allicin Induces p53-Mediated Autophagy in Hep G2 Human Liver Cancer Cells

-

in-vitro,

Liver,

HepG2

 35uM

P53↓, PI3K↓, mTOR↓, Bcl-2↓, AMPK↑, TSC2↑, Beclin-1/ATG6↑, TumAuto↑, tumCV↓, ATG7↑, MMP↓,

239-

AL,

Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways

-

in-vitro,

GC,

SGC-7901

 30ug/ml

Apoptosis↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, BAX↑, Fas↑, tumCV↓, DNAdam↑, ROS↑, Telomerase↓,

5167-

AL,

The Effects of Allicin, a Reactive Sulfur Species from Garlic, on a Selection of Mammalian Cell Lines

-

in-vitro,

Nor,

3T3

-

in-vitro,

BC,

MCF7

-

in-vitro,

Lung,

A549

-

in-vitro,

CRC,

HT-29

Thiols↓, tumCV↓, TumCP↓, GSH↓, GSSG↑, ROS↑,

2646-

AL,

Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress

-

in-vitro,

Pca,

DU145

-

in-vitro,

Melanoma,

RPMI-8226

AntiCan↑, eff↓, ChemoSen↑, ER Stress↑, tumCV↓, DNAdam↑, GSH∅, HSP70/HSPA5↓, UPR↑, β-catenin/ZEB1↓, ROS↑, HO-2↑, SIRT1↑, GlucoseCon∅, lactateProd∅, chemoP↑,

3434-

ALA,

Alpha lipoic acid modulates metabolic reprogramming in breast cancer stem cells enriched 3D spheroids by targeting phosphoinositide 3-kinase: In silico and in vitro insights

-

in-vitro,

BC,

MCF7

-

in-vitro,

BC,

MDA-MB-231

tumCV↓, PI3K↓, p‑Akt↓, p‑P70S6K↓, mTOR↓, ATP↓, GlucoseCon↓, ROS↑, PKM2↓, LDHA↓, Glycolysis↓, ChemoSen↑,

3442-

ALA,

α‑lipoic acid modulates prostate cancer cell growth and bone cell differentiation

-

in-vitro,

Pca,

22Rv1

-

in-vitro,

Pca,

C4-2B

-

in-vitro,

Nor,

3T3

tumCV↓, TumCMig↓, TumCI↓, ROS↑, Hif1a↑, JNK↑, Casp↑, TumCCA↑, Apoptosis↑, selectivity↑,

6597-

Anamu,

Dibenzyl trisulfide inhibits proliferation and induces apoptosis of HN30 cells via Akt/ p53 signaling pathway

-

in-vitro,

HNSCC,

HN30

-

in-vitro,

Tong,

SCC25

tumCV↓, Apoptosis↑, MMP↓, cl‑Casp3↑, Bcl-2↓, p‑Akt↓, p‑P53↑, TumCP↓,

1007-

And,

In vitro and in silico evaluation of Andrographis paniculata ethanolic crude extracts on fatty acid synthase expression on breast cancer cells

-

in-vitro,

BC,

MCF7

mice

-

in-vitro,

BC,

EMT6

tumCV↓, i-FASN↓,

6394-

ANE,

Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis

TNF-α↓, NF-kB↓, Casp↑, tumCV↓,

6395-

ANE,

Anethole suppressed cell survival and induced apoptosis in human breast cancer cells independent of estrogen receptor status

-

in-vitro,

BC,

MCF7

-

in-vitro,

BC,

MDA-MB-231

Apoptosis↑, tumCV↓, TumCP↓,

1008-

Api,

Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling

-

in-vitro,

CRC,

HCT116

0-50uM

38.15 ± 1.32 μM

-

in-vitro,

CRC,

SW480

Wnt/(β-catenin)↓, β-catenin/ZEB1↓, TumAuto↑, Akt↓, mTOR↓, tumCV↓, TumCCA↑, TumAuto↑, p‑Akt↓, p‑p70S6↓, p‑4E-BP1↓,

1024-

Api,

CUR,

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects

-

vitro+vivo,

Melanoma,

A375

 (30 μM) for 24 h

-

in-vitro,

Melanoma,

A2058

-

in-vitro,

Melanoma,

RPMI-7951

TumCG↓, Apoptosis↑, PD-L1↓, STAT1↓, tumCV↓, T-Cell↑,

1536-

Api,

Apigenin causes necroptosis by inducing ROS accumulation, mitochondrial dysfunction, and ATP depletion in malignant mesothelioma cells

-

in-vitro,

MM,

MSTO-211H

0, 10, 30, and 50 µM) of apigenin for 48 h and 72 h

-

in-vitro,

MM,

H2452

tumCV↓, ROS↑, MMP↓, ATP↓, Apoptosis↑, Necroptosis↑, DNAdam↑, TumCCA↑, Casp3↑, cl‑PARP↑, MLKL↑, p‑RIP3↑, Bax:Bcl2↑, eff↓, eff↓,

1563-

Api,

MET,

Metformin-induced ROS upregulation as amplified by apigenin causes profound anticancer activity while sparing normal cells

-

in-vitro,

Nor,

HDFa

metformin (5 mM), apigenin (1 or 20 µM),

-

in-vitro,

PC,

AsPC-1

-

in-vitro,

PC,

MIA PaCa-2

-

in-vitro,

Pca,

DU145

-

in-vitro,

Pca,

LNCaP

-

in-vivo,

NA,

NA

mice

selectivity↑, selectivity↑, selectivity↓, ROS↑, eff↑, tumCV↓, MMP↓, Dose∅, eff↓, DNAdam↑, Apoptosis↑, TumAuto↑, Necroptosis↑, p‑P53↑, BIM↑, BAX↑, p‑PARP↑, Casp3↑, Casp8↑, Casp9↑, Cyt‑c↑, Bcl-2↓, AIF↑, p62↑, LC3B↑, MLKL↑, p‑MLKL↓, RIP3↑, p‑RIP3↑, TumCG↑, TumW↓,

5137-

ART/DHA,

Autophagy-dependent cell cycle arrest in esophageal cancer cells exposed to dihydroartemisinin

-

vitro+vivo,

ESCC,

Eca109

tumCV↓, TumCCA↑, ROS↑, TumAuto↑, eff↓, TRF2↓, TumCP↓,

5133-

ART/DHA,

Dihydroartemisinin Exerts Anti-Tumor Activity by Inducing Mitochondrion and Endoplasmic Reticulum Apoptosis and Autophagic Cell Death in Human Glioblastoma Cells

-

in-vitro,

GBM,

U87MG

-

in-vitro,

GBM,

U251

AntiTum↑, tumCV↓, Apoptosis↓, MMP↓, Cyt‑c↑, Casp9↑, CHOP/DDIT3↑, GRP78/BiP↑, eIF2α↑, Casp12↑, ER Stress↑, TumAuto↑, ROS↑,

5130-

ART/DHA,

Dihydroartemisinin Induces Apoptosis in Human Bladder Cancer Cell Lines Through Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cytochrome C Pathway

-

in-vitro,

Bladder,

T24/HTB-9

tumCV↓, eff↓, Apoptosis↑, Casp3↑, ROS↑, Cyt‑c↑, MMP↓, Bcl-2↓, BAX↑, MOMP↑, TumCG↓,

2576-

ART/DHA,

AL,

The Synergistic Anticancer Effect of Artesunate Combined with Allicin in Osteosarcoma Cell Line in Vitro and in Vivo

-

in-vitro,

OS,

MG63

-

in-vivo,

NA,

NA

0 mg/kg per
day, i.p.), allicin (5 mg/kg per day, i.p.)

mice

eff↑, tumCV↓, Casp3↑, Casp9↑, Apoptosis↑, TumCG↓,

1369-

Ash,

Withaferin A inhibits cell proliferation of U266B1 and IM-9 human myeloma cells by inducing intrinsic apoptosis

-

in-vitro,

Melanoma,

U266

9 μM

tumCV↓, Apoptosis↑, BAX↑, Cyt‑c↑, Bcl-2↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp9↑, ROS↑, eff↓,

1368-

Ash,

Cisplatin,

Withania somnifera Root Extract Enhances Chemotherapy through ‘Priming’

-

in-vitro,

Colon,

HT-29

1 μg/mL, 5 μg/mL and 10 μg/mL W. somnifera for 48 h

-

in-vitro,

BC,

MDA-MB-231

tumCV↓, *toxicity↓, ROS↑, mitResp↓, ChemoSen↑,

1433-

Ash,

SFN,

A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells

-

in-vitro,

BC,

MCF7

1.0 µM WA and 5.0 µM SFN

-

in-vitro,

BC,

MDA-MB-231

eff↑, Bcl-2↓, BAX↑, tumCV↓, DNMT1↓, DNMT3A↓, HDAC↓,

5389-

AsP,

Tras,

ASCORBYL PALMITATE ENHANCES ANTI-PROLIFERATIVE EFFECT OF TRASTUZUMAB IN HER2-POSITIVE BREAST CANCER CELLS

tumCV↓, eff↑, P53↑, BAX↑, Casp3↑, Casp8↑, Bcl-2↓, Apoptosis↑, p‑p38↓, ERK↓, PI3K↓,

4822-

ASTX,

Rad,

Astaxanthin Synergizes with Ionizing Radiation (IR) in Oral Squamous Cell Carcinoma (OSCC)

tumCV↓, selectivity↑, RadioS↑, GPx4↓, Ferroptosis↑,

4818-

ASTX,

MEL,

Effect of astaxanthin and melatonin on cell viability and DNA damage in human breast cancer cell lines

-

in-vitro,

BC,

MDA-MB-231

-

in-vitro,

BC,

T47D

-

in-vitro,

Nor,

MCF10

TumCD↑, DNAdam↑, *antiOx↑, *AntiTum↑, Inflam↓, tumCV↓, Bcl-2↓, Apoptosis↓, selectivity↑, eff↑, Dose↓,

4809-

ASTX,

Astaxanthin Inhibits Proliferation of Human Gastric Cancer Cell Lines by Interrupting Cell Cycle Progression

-

in-vitro,

GC,

AGS

50 and 100 μM significantly suppressed cell proliferation

could not reach IC50 even under 100 μM.

-

in-vitro,

GC,

MKN45

tumCV↓, TumCP↓, TumCCA↑, p‑ERK↓, p27/CDKN1B↑, cycD1/CCND1↓, CDK4↓,

Showing Research Papers: 1 to 50 of 523
Page 1 of 11 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 523

Pathway results for Effect on Cancer / Diseased Cells:

NA, unassigned(tgid=0) ⓘ

compII↓, 1, CXCR3↓, 1, Ingr↝, 2, IQGAP3↓, 1, JHDM1D-AS1↓, 1, Ku70/XRCC6↓, 1, LIFR/CD118↓, 1, miR-107↑, 1, miR-149↑, 1, miR-224↓, 1, miR-422a↑, 1, miR-542↓, 1, MMP16↓, 1, NA↓, 2, NHEJ↓, 1, O-Glc↓, 1, PRKCQ/PKCθ↓, 1, SALL4↓, 1, SBF2-AS1↓, 1, SERPINH1/HSP47↓, 1, SUV39H↓, 2, TRAF2↑, 1, XRCC1↓, 1,

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1, antiOx↓, 2, antiOx↑, 9, ARE/EpRE↑, 1, Catalase↓, 6, Catalase↑, 4, compI↓, 3, CYP1A1↓, 1, CYP1A1↑, 1, Fenton↑, 2, Ferroptosis↓, 1, Ferroptosis↑, 13, GPx↓, 2, GPx↑, 1, GPx1↓, 1, GPx4↓, 7, GPx4∅, 1, GSH↓, 21, GSH↑, 3, GSH⇅, 1, GSH∅, 1, GSH/GSSG↓, 1, GSR↓, 2, GSS↑, 1, GSSG↑, 1, H2O2↑, 1, e-H2O2↓, 1, i-H2O2∅, 1, HO-1↓, 6, HO-1↑, 7, HO-2↓, 1, HO-2↑, 1, Iron↑, 3, Iron↝, 1, i-Iron↓, 1, i-Iron↑, 1, Keap1↓, 1, lipid-P↓, 6, lipid-P↑, 9, MDA↑, 7, NQO1?, 1, NQO1↑, 1, NRF2↓, 10, NRF2↑, 9, p‑NRF2↑, 2, OXPHOS↓, 2, OXPHOS↑, 2, p66Shc↓, 1, p66Shc↑, 1, PARK2↑, 2, Prx↓, 1, ROS?, 2, ROS↓, 24, ROS↑, 203, ROS⇅, 1, ROS∅, 3, i-ROS↑, 1, mt-ROS↑, 9, SIRT3↓, 1, SIRT3↑, 1, SOD↓, 7, SOD↑, 4, SOD1↑, 1, SOD2↓, 3, SOD2↑, 3, TAC↓, 1, TAC↑, 2, TBARS↑, 2, Thiols↓, 2, Thiols↝, 1, TKT↓, 1, Trx↓, 2, Trx1↑, 1, TrxR↓, 2, xCT/SLC7A11↓, 1,

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 1, STEAP3↓, 1, Tf↑, 1,

Mitochondria & Bioenergetics(tgid=3) ⓘ

AIF↑, 11, AIF↝, 1, ATP↓, 14, BOK↑, 1, CDC2↓, 1, CDC25↓, 6, compIII↓, 1, EGF↓, 2, ETC↓, 2, KIF2C↓, 1, MEK↓, 4, p‑MEK↑, 1, mitResp↓, 2, mitResp↑, 1, MMP↓, 88, MMP↑, 2, MPT↑, 4, mtDam↑, 24, OCR↓, 4, PINK1↑, 2, e-Raf↓, 1, XIAP↓, 9,

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACC↓, 2, p‑ACC↑, 1, ACLY↓, 1, AKT1↓, 1, ALAT↓, 3, AMP↑, 1, AMPK↑, 16, p‑AMPK↑, 2, ATG7↑, 1, Cav1↓, 1, cMyc↓, 15, cMyc↑, 1, ECAR↓, 2, ECAR↝, 1, FAO↓, 1, FASN↓, 3, FASN↑, 1, i-FASN↓, 1, FBPase↑, 1, GLO-I↓, 1, glucoNG↑, 1, glucose↓, 2, GlucoseCon↓, 8, GlucoseCon∅, 1, GlutMet↓, 1, Glycolysis↓, 23, Histones↑, 1, HK2↓, 7, HMG-CoA↓, 1, IDH1↑, 1, lactateProd↓, 12, lactateProd∅, 1, LDH↓, 4, LDH↑, 6, LDHA↓, 4, LDL↓, 1, lipidLev↓, 1, lipoGen↓, 2, NADPH↓, 1, PDH↓, 1, PDH↑, 1, PDHB↓, 1, PDK1 / PDPK1?, 2, PDK1 / PDPK1↓, 3, PDKs↓, 1, PFK↓, 2, PGK1↓, 1, PI3k/Akt/mTOR↓, 2, PKM2↓, 11, POLD1↓, 1, PPARγ↑, 6, p‑S6↓, 1, SIRT1↓, 1, SIRT1↑, 2, p‑STK11/LKB1↑, 1, TCA↓, 1, TS↓, 1, Warburg↓, 1, β-oxidation↓, 1,

Cell Death(tgid=5) ⓘ

Akt↓, 71, Akt↑, 4, p‑Akt↓, 32, APAF1↑, 4, Apoptosis?, 1, Apoptosis↓, 8, Apoptosis↑, 247, Apoptosis∅, 1, mt-Apoptosis↑, 2, ASK1↑, 1, BAD↓, 1, BAD↑, 4, Bak↑, 3, BAX↓, 2, BAX↑, 93, Bax:Bcl2↑, 24, Bcl-2↓, 97, Bcl-2↑, 2, Bcl-xL↓, 15, Bcl-xL↑, 2, BID↑, 3, BIM↑, 2, Casp↑, 21, cl‑Casp↑, 2, proCasp↑, 1, cl‑Casp1↑, 1, Casp12↑, 6, Casp3↓, 1, Casp3↑, 138, cl‑Casp3↑, 34, proCasp3↓, 1, proCasp3↑, 1, pro‑Casp3↓, 1, Casp6↓, 1, Casp6↑, 2, Casp7↑, 20, cl‑Casp7↑, 2, Casp8↓, 1, Casp8↑, 27, Casp8∅, 1, cl‑Casp8↑, 4, Casp9↓, 2, Casp9↑, 73, cl‑Casp9↑, 16, cFLIP↓, 2, Chk2↑, 1, p‑Chk2↑, 1, CK2↓, 1, Cyt‑c↓, 1, Cyt‑c↑, 57, Diablo↑, 1, DR4↑, 3, DR5↑, 3, Endon↑, 1, FADD↑, 2, Fas↑, 5, FasL↑, 5, Ferroptosis↓, 1, Ferroptosis↑, 13, cl‑GSDMD↑, 1, GSDME↑, 1, hTERT/TERT↓, 3, IAP1↓, 1, iNOS↓, 3, JNK↓, 3, JNK↑, 10, p‑JNK↓, 1, p‑JNK↑, 5, MAPK↓, 10, MAPK↑, 8, MAPK↝, 1, p‑MAPK↓, 1, p‑MAPK↑, 2, Mcl-1↓, 13, MDM2↓, 8, MLKL↑, 2, p‑MLKL↓, 1, MOMP↓, 1, MOMP↑, 2, Myc↓, 2, NAIP↓, 1, Necroptosis↑, 3, necrosis↑, 3, NOXA↑, 2, p27/CDKN1B↓, 1, p27/CDKN1B↑, 13, p38↓, 4, p38↑, 5, p‑p38↓, 3, p‑p38↑, 6, PDCD4↑, 1, proApCas↑, 1, Proteasome↓, 1, PUMA↑, 4, Pyro↑, 3, survivin↓, 35, Telomerase↓, 3, TRAIL↑, 2, TRPV1↑, 1, TumCD↓, 1, TumCD↑, 16, TUNEL↑, 1, YAP/TEAD↓, 2,

Kinase & Signal Transduction(tgid=6) ⓘ

CaMKII ↓, 1, CaMKII ↑, 1, cSrc↓, 1, HER2/EBBR2↓, 3, p‑HER2/EBBR2↓, 1, p‑p70S6↓, 1, Sp1/3/4↓, 6, TSC2↑, 2,

Transcription & Epigenetics(tgid=7) ⓘ

ChrMod↝, 1, cJun↓, 1, p‑cJun↑, 1, ac‑H3↑, 3, ac‑H3↝, 1, ac‑H4↑, 3, miR-21↓, 2, miR-27a-3p↓, 1, other↓, 1, other↑, 3, other↝, 6, pRB↓, 1, p‑pRB↓, 1, sonoS↑, 1, TET3↑, 1, TLE1↓, 1, tumCV↓, 523, tumCV∅, 1,

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 2, c-ATF6↑, 1, CHOP/DDIT3↑, 18, eIF2α↑, 3, p‑eIF2α↑, 5, ER Stress↑, 30, ERStress↑, 1, GRP78/BiP↑, 14, GRP94↑, 2, HSF1↓, 1, HSP27↝, 1, HSP70/HSPA5↓, 3, HSP70/HSPA5↑, 1, HSP70/HSPA5⇅, 1, HSP70/HSPA5↝, 1, HSP90↓, 3, IRE1↑, 2, PERK↑, 3, p‑PERK↑, 4, UPR↑, 3, XBP-1↓, 1,

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1, ATG5↑, 4, Beclin-1/ATG6↓, 2, Beclin-1/ATG6↑, 10, BNIP3↑, 1, LC3B↑, 3, LC3B-II↑, 2, LC3I↑, 2, LC3II↑, 10, LC3s↑, 1, MitoP↑, 2, p62↓, 6, p62↑, 4, SESN2↑, 1, TumAuto↓, 2, TumAuto↑, 36,

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 1, ATR↑, 1, BRCA1↓, 2, CHK1↓, 1, DFF45↑, 1, DNA-PK↑, 1, DNAdam↓, 1, DNAdam↑, 49, DNMT1↓, 4, DNMT3A↓, 3, DNMT3B↓, 1, DNMTs↓, 2, P53?, 1, P53↓, 2, P53↑, 48, P53⇅, 1, P53↝, 1, p‑P53↑, 2, p53 Wildtype↓, 1, PARP↓, 4, PARP↑, 13, p‑PARP↑, 1, cl‑PARP↓, 2, cl‑PARP↑, 52, PARP1↑, 2, cl‑PARP1↑, 3, PCNA↓, 13, SIRT6↑, 1, TP53↑, 1, γH2AX↑, 6, p‑γH2AX↑, 2,

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 8, CDK1↑, 1, p‑CDK1↑, 1, CDK2↓, 11, CDK2↑, 1, CDK4↓, 14, CDK4↑, 1, cycA1/CCNA1↓, 5, cycA1/CCNA1↑, 1, CycB/CCNB1↓, 9, CycB/CCNB1↑, 3, cycD1/CCND1↓, 41, CycD3↓, 3, CycD3↑, 1, cycE/CCNE↓, 12, cycE1↓, 2, E2Fs↓, 2, mitA↑, 2, P21?, 1, P21↓, 4, P21↑, 31, PLK1↓, 1, RB1↓, 2, RB1↑, 1, p‑RB1↓, 2, Securin↓, 1, TumCCA?, 3, TumCCA↓, 2, TumCCA↑, 137, TumCCA⇅, 1,

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 2, ALDH↓, 2, ALDH1A1↓, 1, Axin2↓, 1, BMI1↓, 1, CD133↓, 5, CD24↓, 2, CD44↓, 4, cDC2↓, 2, CDK8↓, 1, CEBPA↑, 1, cFos↓, 2, CIP2A↓, 1, cMET↓, 1, p‑cMET↑, 1, CSCs↓, 16, CSCsMark↓, 1, CTNNB1↓, 1, CTSB↓, 2, CTSD↓, 2, Diff↓, 1, Diff↑, 1, EMT?, 1, EMT↓, 28, ERK↓, 22, ERK↑, 4, ERK↝, 1, p‑ERK↓, 12, p‑ERK↑, 2, FOXO3↓, 2, p‑FOXO3↓, 1, FOXO4↓, 1, GSK‐3β↓, 2, GSK‐3β↑, 4, p‑GSK‐3β↓, 3, HDAC↓, 7, HDAC1↓, 4, HDAC2↓, 4, HDAC3↓, 2, HH↓, 3, HMGCR↓, 1, HMTs↓, 1, HRAS↓, 1, IGF-1?, 1, IGF-1↓, 5, IGF-1R↓, 2, LRP6↓, 1, miR-34a↓, 1, miR-34a↑, 2, mTOR↓, 40, mTOR↑, 2, p‑mTOR↓, 8, mTORC1↓, 3, mTORC2↓, 1, mTORC2↑, 1, Nanog↓, 3, Nestin↓, 2, NOTCH↓, 3, NOTCH1↓, 3, NOTCH3↓, 1, OCT4↓, 5, p‑P70S6K↓, 2, PI3K↓, 48, PI3K↑, 1, p‑PI3K↓, 11, PTEN↑, 5, RAS↓, 4, RAS↑, 1, Shh↓, 1, SOX2↓, 5, Src↓, 1, STAT↓, 3, STAT1↓, 1, STAT3↓, 32, STAT3↑, 1, p‑STAT3↓, 14, STAT4↑, 1, STAT5↓, 2, TAZ↓, 1, TBX15↑, 1, TCF↓, 2, TK1↓, 1, TOP1↓, 1, TOP2↓, 3, TRF2↓, 1, TRPM7↓, 3, TumCG?, 2, TumCG↓, 72, TumCG↑, 1, Wnt↓, 11, Wnt/(β-catenin)↓, 4,

Migration(tgid=13) ⓘ

5LO↓, 2, AKR1C2↓, 1, Alix/AIP‑1↓, 1, annexin II↓, 1, AntiAg↑, 1, AP-1↓, 1, APC↑, 1, Brk/PTK6↓, 1, Ca+2↓, 2, Ca+2↑, 20, Ca+2↝, 3, i-Ca+2↓, 1, i-Ca+2↑, 4, CD31/PECAM-1↓, 1, Cofilin↓, 1, p‑Cofilin↑, 2, COL1↓, 1, COL4↓, 1, E-cadherin↓, 2, E-cadherin↑, 12, ER-α36↓, 2, ER-α36↝, 1, F-actin↓, 1, F-actin↑, 1, FAK↓, 3, p‑FAK↓, 1, Fibronectin↓, 2, FTO↓, 1, Ki-67↓, 17, KRAS↓, 4, LEF1↓, 1, MET↑, 1, miR-139-5p↑, 1, miR-155↓, 1, miR-340↓, 1, MMP1↓, 3, MMP2↓, 32, MMP3↓, 2, MMP7↓, 3, MMP7∅, 1, MMP9↓, 26, MMP9:TIMP1↓, 1, MMPs↓, 12, N-cadherin↓, 7, N-cadherin↑, 1, PAK1↓, 2, PKA↓, 2, PKCδ↓, 3, PKCδ↑, 1, proline↓, 1, PTK2B / PYK2↓, 1, Rac1↓, 2, Rho↓, 1, Rho↑, 1, RIP3↑, 1, p‑RIP3↑, 2, Slug?, 1, Slug↓, 7, SMAD2↓, 1, SMAD3↓, 3, Snail?, 1, Snail↓, 8, Snail↑, 1, SOX4↓, 1, TET1↑, 3, TGF-β↓, 3, TIMP1↑, 2, TIMP2↓, 1, TIMP2↑, 2, TRIB3↑, 1, TumCI↓, 64, TumCMig↓, 81, TumCMig⇅, 1, TumCP↓, 101, TumMeta↓, 24, TumMeta↑, 2, Twist↓, 7, TXNIP↑, 1, uPA↓, 2, VCAM-1↓, 1, Vim?, 1, Vim↓, 9, Vim↑, 1, Zeb1↓, 1, α-SMA↓, 1, α-SMA↑, 2, β-catenin/ZEB1↓, 17, β-catenin/ZEB1↑, 1,

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 23, angioG↑, 1, ATF4↑, 4, EGFR↓, 16, p‑EGFR↓, 1, Endoglin↑, 1, eNOS↓, 1, EPR↑, 3, HIF-1↓, 4, Hif1a↓, 14, Hif1a↑, 1, LOX1↓, 1, NO↓, 1, VEGF↓, 24, VEGFR2/KDR/Flk1↓, 3, ZBTB10↑, 1,

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 2, BBB↑, 1, BBB∅, 1, GLUT1↓, 3, NHE1↓, 1, P-gp/ABCB1↓, 7, sonoP↑, 2,

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 2, CD4+↑, 3, COX1↓, 2, COX2/PTGS2↓, 21, COX2/PTGS2↑, 1, CRP↓, 1, CXCc↓, 1, CXCR4↓, 2, FOXP3↑, 1, HMGB1↓, 2, IFN-γ↓, 1, IKKα↓, 3, IKKα↑, 1, IL1↓, 1, IL1↑, 1, IL10↓, 1, IL17↓, 1, IL18↓, 1, IL1β↓, 6, IL1β↑, 1, IL4↓, 1, IL6↓, 14, IL8↓, 3, Imm↑, 6, Inflam↓, 20, p‑IκB↓, 1, JAK↓, 1, JAK1↓, 4, JAK2↓, 6, p‑JAK2↓, 1, MCP1/CCL2↓, 1, MIP2↓, 1, MyD88↑, 1, NF-kB↓, 59, NF-kB↑, 3, NF-kB↝, 1, p‑NF-kB↑, 1, NK cell↑, 1, p50↓, 1, p65↓, 4, p‑p65↓, 3, PD-1↓, 1, PD-L1↓, 5, PD-L1↑, 1, PGE2↓, 5, PSA↓, 2, T-Cell↑, 1, Th1 response↑, 1, TLR4↓, 3, TLR4↑, 1, TNF-α↓, 14, TNF-α↑, 4,

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1, NOX↓, 1, pH↓, 1, pH↑, 3,

Synaptic & Neurotransmission(tgid=18) ⓘ

Protein Aggregation(tgid=19) ⓘ

NLRP3↓, 2, NLRP3↑, 1,

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 3, CDK6↓, 9, CDK6↑, 1, CYP11A1↓, 1, DHT↓, 1, ERβ/ESR2↑, 1, EstroRS/ERS↓, 1, HSD3B↓, 1, SRD5A1↑, 1, StAR↓, 1, testos↓, 1,

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 6, BioAv↑, 11, BioAv↝, 3, BioEnh↑, 1, ChemoSen↑, 64, Dose?, 1, Dose↓, 3, Dose↑, 1, Dose⇅, 1, Dose↝, 46, Dose∅, 5, eff?, 1, eff↓, 67, eff↑, 89, eff⇅, 1, eff↝, 3, Half-Life↓, 2, Half-Life↝, 1, MDR1↓, 2, MDR1↑, 1, RadioS↑, 17, selectivity?, 1, selectivity↓, 2, selectivity↑, 108, TET2↓, 1, TET2↑, 1,

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 3, ALP↓, 1, AR↓, 3, AST↓, 2, BMPs↑, 1, BRCA1↓, 2, CRP↓, 1, EGFR↓, 16, p‑EGFR↓, 1, EstroRS/ERS↓, 1, HER2/EBBR2↓, 3, p‑HER2/EBBR2↓, 1, hTERT/TERT↓, 3, IL6↓, 14, Ki-67↓, 17, KRAS↓, 4, LDH↓, 4, LDH↑, 6, Myc↓, 2, PD-L1↓, 5, PD-L1↑, 1, PSA↓, 2, SLC6A3?, 1, TG/TAG↓, 1, TP53↑, 1, TRIB3↑, 1,

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1, AntiCan↑, 35, AntiCan⇅, 1, AntiDiabetic↑, 1, antiNeop↑, 2, AntiTum↑, 13, AntiTum⇅, 1, cardioP↑, 5, chemoP↓, 1, chemoP↑, 9, chemoPv↑, 10, ChemoSideEff↓, 1, hepatoP↑, 2, neuroP↑, 5, OS↑, 7, Pain↓, 1, radioP↑, 1, RenoP↑, 1, Risk↓, 1, toxicity↓, 12, toxicity↝, 3, toxicity∅, 1, TumVol↓, 23, TumVol↑, 1, TumVol∅, 1, TumW↓, 10, TumW∅, 1, Weight↑, 1, Weight∅, 1, Wound Healing↑, 1,

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 1, CD8+↑, 4,
Total Targets: 765

Pathway results for Effect on Normal Cells:

NA, unassigned(tgid=0) ⓘ

AntiBio↑, 5, cough?, 1, diuretic↑, 1, Ingr↝, 1, SoreThr?, 1, Stress↓, 1,

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 39, Bil↓, 1, Catalase↑, 9, CYP2E1↓, 1, GPx↑, 9, GSH↑, 14, GSR↑, 1, GSTs↑, 5, HO-1↓, 1, HO-1↑, 4, Iron↑, 1, Keap1↓, 1, lipid-P↓, 10, MDA↓, 6, Nrf1↑, 1, NRF2↑, 9, RNS↓, 1, ROS↓, 25, ROS↑, 1, ROS∅, 1, SOD?, 1, SOD↑, 9, TAC↑, 1, uricA↓, 1, VitC↑, 2, VitE↑, 1,

Mitochondria & Bioenergetics(tgid=3) ⓘ

ATP↓, 1, MMP↑, 1,

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 6, AMPK↓, 1, p‑CREB↑, 1, DGAT1↓, 1, FASN↓, 1, glucose↓, 1, NAD↓, 1, NADPH↓, 1,

Cell Death(tgid=5) ⓘ

Akt↓, 1, Apoptosis↓, 3, BAX↓, 2, Bcl-2↓, 1, BMP2↑, 1, Casp3↓, 5, proCasp3↓, 1, cl‑Casp8↑, 1, Casp9↓, 2, Cyt‑c↓, 2, GADD34↓, 1, iNOS↓, 3,

Transcription & Epigenetics(tgid=7) ⓘ

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1, LC3II↓, 1, p62↑, 1,

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↑, 1, P53↓, 1, PARP↑, 1,

Cell Cycle & Senescence(tgid=11) ⓘ

P21↓, 1, P21↑, 1,

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ERK↑, 1, GSK‐3β↓, 1, RUNX2↑, 1, STAT↓, 1, VDR↑, 1, VGSC↓, 1,

Migration(tgid=13) ⓘ

5LO↓, 2, AntiAg↑, 3, AP-1↓, 1, Ca+2↓, 1, Cartilage↑, 1, CEA↓, 1, COL1↑, 1, p‑Rac1↓, 1,

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 2, ATF4↓, 1, NO↓, 1,

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1, GastroP↑, 1, P-gp/ABCB1↓, 1,

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2/PTGS2↓, 7, IFN-γ↓, 1, IKKα↑, 1, IL1↓, 1, IL10↓, 3, IL17↓, 2, IL1β↓, 5, IL6↓, 7, Imm↓, 1, Imm↑, 2, Inflam↓, 34, MCP1/CCL2↓, 1, NF-kB?, 1, NF-kB↓, 6, NK cell↑, 1, PGE2↓, 4, PSA∅, 1, TNF-α↓, 11,

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1, AChE↓, 1, BDNF↓, 1, MAOA↓, 1, tau↓, 2,

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1, Aβ↓, 3, NLRP3↓, 2,

Hormonal & Nuclear Receptors(tgid=20) ⓘ

GR↑, 2, testos↑, 1,

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 5, BioAv↑, 4, BioAv↝, 4, Dose↝, 5, eff↑, 7, Half-Life↑, 1, Half-Life↝, 1,

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 6, ALP↓, 3, AST↓, 5, Bil↓, 1, BloodF↑, 1, BP↓, 2, CEA↓, 1, creat↓, 1, GutMicro↑, 1, IL6↓, 7, PSA∅, 1, Urea↓, 1,

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1, antiAll↑, 3, AntiArt↑, 1, AntiCan↑, 3, AntiDiabetic↑, 10, antiNeop↑, 1, AntiP↑, 2, AntiTum↑, 3, Bone Healing↑, 1, cardioP↑, 9, chemoP↑, 5, chemoPv↑, 2, cognitive↓, 1, cognitive↑, 1, hepatoP↑, 12, memory↑, 2, neuroP↑, 16, Obesity↓, 1, Pain↓, 3, RenoP↑, 1, toxicity↓, 18, toxicity↑, 1, toxicity↝, 6, toxicity∅, 5, Wound Healing↑, 1,

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 1, AntiViral↑, 3, Bacteria↓, 7,
Total Targets: 159

Scientific Paper Hit Count for: tumCV, Cell Viability

21 Silver-NanoParticles
17 Quercetin
13 Cisplatin
12 Curcumin
12 Sulforaphane (mainly Broccoli)
12 Thymoquinone
11 Honokiol
9 Fisetin
9 Kaempferol
9 Phenethyl isothiocyanate
8 Betulinic acid
8 Dandelion Root
8 Magnetic Fields
7 SonoDynamic Therapy UltraSound
7 Berberine
7 Capsaicin
7 Eugenol
7 doxorubicin
7 Cynaropicrin
7 Gallic acid
7 Licochalcone A
7 Luteolin
7 Marjoram (Origanum majorana)
7 Shikonin
6 Cynara scolymus/Globe Artichoke/Artichoke Extract
6 Allicin (mainly Garlic)
6 Radiotherapy/Radiation
6 Carvacrol
6 Chrysin
6 Resveratrol
6 Hyperoside
6 Ivermectin
5 chaetocin
5 Crocetin
5 Emodin
5 Formononetin
5 Ginkgetin
5 Licorice
4 Apigenin (mainly Parsley)
4 Metformin
4 Artemisinin
4 Baicalein
4 Berbamine
4 Biochanin A
4 Gemcitabine (Gemzar)
4 Caffeic Acid Phenethyl Ester (CAPE)
4 Chlorogenic acid
4 Carvone
4 Eurycomanone
4 Shilajit/Fulvic Acid
4 Graviola
4 iodine
4 isoquercitrin
4 Propolis -bee glue
4 Rosmarinic acid
4 α-Santalol/Sandalwood oil
4 Silymarin (Milk Thistle) silibinin
4 Vitamin C (Ascorbic Acid)
4 Vitexin
3 Ashwagandha(Withaferin A)
3 Astaxanthin
3 Beta-Caryophyllene
3 Carnosic acid
3 5-fluorouracil
3 chitosan
3 Selenium
3 Citric Acid
3 CUSP9
3 Dichloroacetate
3 Echinacea
3 eicosapentaenoic acid
3 Evodiamine
3 Fucoidan
3 Hibiscus sabdariffa
3 Magnolol
3 Hyperthermia
3 HydroxyTyrosol
3 Juglone
3 Linalool
3 Lycopene
3 Methylene blue
3 Magnetic Field Rotating
3 Nimbolide
3 Terpinen-4-ol / Tea Tree Oil
3 Piperlongumine
3 Parthenolide
3 Selenite (Sodium)
3 Urolithin
2 3-bromopyruvate
2 Alpha-Lipoic-Acid
2 Anethole/trans-Anethole
2 Aloe anthraquinones
2 Bacopa monnieri
2 Boswellia (frankincense)
2 brusatol
2 Caffeic acid
2 Centella asiatica / Gotu kola → asiaticoside
2 Cichoric acid / Chicoric acid
2 Coenzyme Q10
2 Polyphenols
2 Copper and Cu NanoParticles
2 Hydroxycinnamic-acid
2 D-limonene
2 tamoxifen
2 EGCG (Epigallocatechin Gallate)
2 Gambogic Acid
2 Garcinol
2 Ginkgolic acids
2 Ginkgo biloba
2 Geraniol
2 Helleborus niger extracts – Christmas Rose
2 Isoliquiritigenin
2 isoorientin
2 Lasiodin
2 SDG/lignans
2 Lutein
2 Iron
2 Gold NanoParticles
2 Methylsulfonylmethane
2 Naringin
2 Piperine
2 Plumbagin
2 salinomycin
2 polyethylene glycol
2 Selenium NanoParticles
2 Chemotherapy
2 Photodynamic Therapy
2 Aflavin-3,3′-digallate
2 Ursolic acid
2 VitK3,menadione
1 Resiquimod
1 DTS(dibenzyl trisulphide) from Anamu
1 Andrographis
1 Ascorbyl Palmitate
1 Trastuzumab
1 Melatonin
1 Atorvastatin
1 Bevacizumab (brand Avastin)
1 borneol
1 Boron
1 α-Bisabolol / Chamomile oil
1 Bullatacin
1 Catechins
1 Cannabidiol
1 Selenate
1 Vitamin E
1 Docosahexaenoic Acid
1 Ellagic acid
1 Cannabichromene
1 Ginkgo biloba-EGb 761
1 Electrical Pulses
1 Ferulic acid
1 Fenbendazole
1 Fennel Oil/Foeniculum vulgare
1 olaparib/LYNPARZA
1 Genistein (soy isoflavone)
1 Ginseng
1 HydroxyCitric Acid
1 Paclitaxel/Taxol
1 Rutin
1 Indole-3-carbinol
1 Isobavachalcone
1 Inositol
1 metronomic chemo
1 itraconazole
1 Lactobacillus
1 lambertianic acid
1 Lapachol
1 Lemongrass Extract/Citral
1 Folic Acid, Vit B9
1 Methyl salicylate / Sweet Birch oil
1 Aspirin
1 immunotherapy
1 Magnesium
1 magnetic nanoparticles
1 Mushroom Chaga
1 Bicarbonate(Sodium)
1 Niclosamide (Niclocide)
1 Oleuropein
1 Propyl gallate
1 Pterostilbene
1 Scoulerine
1 acetazolamide
1 Triphala
1 triptolide
1 Turmerones
1 Vitamin D3
1 Vitamin K2
1 Zerumbone

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:897  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

Home Page